Neoadjuvant therapy for pancreatic cancer: The Duke experience

Surgical Oncology Clinics of North America

Volumn 13, Issue 4, 2004, Pages 675-684

  White, Rebekah R ^a   Tyler, Douglas S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; ENDOSCOPY; HISTOLOGY; HOSPITALIZATION; HUMAN; LAPAROSCOPY; METASTASIS; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; PANCREAS CANCER; PANCREATICODUODENECTOMY; PROGNOSIS; RADIATION DOSE; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TOXICITY; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE I; COMBINED MODALITY THERAPY; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NORTH CAROLINA; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 4444220500     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2004.06.001     Document Type: Review

References (27)

1. T.A. Sohn, C.J. Yeo, J.L. Cameron, L. Koniaris, S. Kaushal, and R.A. Abrams Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 2000 567 579
2. M.H. Kalser, and S.S. Ellenberg Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection [Published erratum appears in Arch Surg 1986;121(9):1045.] Arch Surg 120 8 1985 899 903
3. Gastrointestinal Tumor Study Group Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer Cancer 59 12 1987 2006 2010
4. R. Whittington, M.P. Bryer, D.G. Haller, L.J. Solin, and E.F. Rosato Adjuvant therapy of resected adenocarcinoma of the pancreas Int J Radiat Oncol Biol Phys 21 5 1991 1137 1143
5. M.L. Foo, L.L. Gunderson, D.M. Nagorney, D.C. McLlrath, J.A. van Heerden, and J.S. Robinow Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracil Int J Radiat Oncol Biol Phys 26 3 1993 483 489
6. C.J. Yeo, R.A. Abrams, L.B. Grochow, T.A. Sohn, S.E. Ord, and R.H. Hruban Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience Ann Surg 225 5 1997 621 633
7. J.H. Klinkenbijl, J. Jeekel, T. Sahmoud, R. van Pel, M.L. Couvreur, and C.H. Veenhof Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg 230 6 1999 776 782
8. J.P. Neoptolemos, J.A. Dunn, D.D. Stocken, J. Almond, K. Link, and H. Beger Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial Lancet 358 9293 2001 1576 1585
9. Y. Nukui, V.J. Picozzi, and L.W. Traverso Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Am J Surg 179 5 2000 367 371
10. A. Chakravarthy, R.A. Abrams, C.J. Yeo, L.T. Korman, R.C. Donehower, and R.H. Hruban Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival Int J Radiat Oncol Biol Phys 48 4 2000 1089 1096
11. Gastrointestinal Tumor Study Group Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone J Natl Cancer Inst 80 10 1988 751 755
12. B.J. Fisher, F.E. Perera, W. Kocha, A. Tomiak, M. Taylor, and M. Vincent Analysis of the clinical benefit of 5-fluorouracil and radiation treatment in locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 45 2 1999 291 295
13. P. Legmann, O. Vignaux, B. Dousset, A.J. Baraza, L. Palazzo, and I. Dumontier Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography Am J Roentgenol 170 5 1998 1315 1322
14. Micames C, Jowell P, White R, Paulson E, Nelson R, Morse M, et al. Lower incidence of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA compared to percutaneous FNA. Gastrointest Endosc, in press.
15. R.R. White, E.K. Paulson, K. Freed, M. Keogan, H. Hurwitz, and C. Lee Staging of pancreatic cancer before and after neoadjuvant chemoradiation J Gastrointest Surg 5 6 2001 626 633
16. M.A. Makary, A.L. Warshaw, B.A. Centeno, C.G. Willet, D.W. Rattner, and C. Fernandez-del Castillo Implications of peritoneal cytology for pancreatic cancer management Arch Surg 133 4 1998 361 365
17. R. White, C. Lee, M. Anscher, M. Gottfried, R. Wolff, and M. Keogan Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas Ann Surg Oncol 6 1999 38 45
18. Gerke H, White R, Byrne M, Stiffler H, Mitchell R, Hurwitz H, et al. Preoperative biliary drainage in the setting of neoadjuvant chemoradiation does not increase infectious complications of pancreaticoduodenectomy (Whipple procedure) for periampullary cancers. Dig Liver Dis, in press.
19. R. White, H. Hurwitz, C. Lee, M. Anscher, E. Paulson, and M. Gottfried Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas Ann Surg Oncol 8 10 2001 758 765
20. F. Spitz, J. Abruzzese, J. Lee, P. Pisters, A. Lowy, and C. Fenoglio Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas J Clin Oncol 15 1997 928 937
21. J.P. Hoffman, S. Lipsitz, T. Pisansky, J.L. Weese, L. Solin, and A.B. Benson III Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study J Clin Oncol 16 1 1998 317 323
22. D.S. Lu, H.A. Reber, R.M. Krasny, B.M. Kadell, and J. Sayre Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT Am J Roentgenol 168 6 1997 1439 1443
23. V. Raptopoulos, M.L. Steer, R.G. Sheiman, T.G. Vrachliotis, C.A. Gougoutas, and J.S. Movson The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer: correlation with findings at surgery Am J Roentgenol 168 4 1997 971 977
24. O. Ishikawa, H. Ohhigashi, T. Teshima, M. Chatani, T. Inoue, and S. Tanaka Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreatoduodenal region J Surg Oncol 40 3 1989 143 151
25. P.W. Pisters, W.A. Hudec, K.R. Hess, J.E. Lee, J.N. Vauthey, and S. Lahoti Effect of preoperative biliary decompression on pancreaticoduodenectomy- associated morbidity in 300 consecutive patients Ann Surg 234 1 2001 47 55
26. H.Q. Xiong, and J.L. Abbruzzese Epidermal growth factor receptor-targeted therapy for pancreatic cancer Semin Oncol 29 5 Suppl 14 2002 31 337
27. G. Purcell, R. White, and D. Tyler Preferences affect treatment decisions for pancreatic cancer J Am Coll Surg 195 3 2002 S54